CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF ADAMANTANE DERIVATIVE IN THERAPY OF ASTHENIC DISORDERS IN EARLY FORMS OF CHRONIC BRAIN ISCHEMIA

A non-specific stress-induced overload   of  limbic-reticular emotiogenic structures under   the deficiency conditions of endogenous energy  resources is the  main  mechanism for development of asthenic disorders  with  early  developing chronic brain  ischemia among  veterans  of recent  wars,  upo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. V. Davydova, A. V. Zurochka
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2017
Materias:
Acceso en línea:https://doaj.org/article/985bde6ab0b048fb897547a27ae7c9b8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:A non-specific stress-induced overload   of  limbic-reticular emotiogenic structures under   the deficiency conditions of endogenous energy  resources is the  main  mechanism for development of asthenic disorders  with  early  developing chronic brain  ischemia among  veterans  of recent  wars,  upon  their  return to civilian  life. We observed  a group  of 30 Afghan  veterans  with  early forms  of chronic brain  ischemia and manifestations of psychogenic asthenic syndrome. When treating psychogenic asthenic syndrome in the veterans of recent  military  conflicts, an adamantane derivative  administered as a course  treatment, at a dose of 50 mg 2 times daily causes psychostimulant, anxiolytic, vegetotropic, antihypotymic, and hypnotic pharmacological effects, with reduction of main psychopathological and somatoneurological symptoms.A notable immunotropic effect  of the  drug  was revealed, being  expressed  as enhanced immunopoiesis; activation of innate defense  mechanisms; expansion of Treg lymphocyte population, suggestive for increased suppressor  effect  upon  the  mechanisms of autoimmune aggression;  implementation of cell differentiation/ proliferative effect; anti-apoptogenic properties; anti-inflammatory activity (reduction of TNFα, IL-8, hsCRP, along with IL-2  increase) associated with reduced functional activity of mononuclear cells; vasotropic action expressed  as normalized balance of vasoactive  factors  (nitric  oxide,  endothelin-1), decrease of nitrotyrosine concentration, suggesting  the  nitrosylation stress reduction. The  actoprotective drug  effect  is implemented due to a combined psychostimulant, vasotropic, proliferative effects.  It may be expressed  in terms  of higher efficiency and optimization of systemic hemodynamic parameters.